4
Total investments
2
Early stage
2
Mid stage
0
Late stage
13y
Years active
Portfolio
4 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Private Investor
Jan 2020
Brand’s First Predictive Platform to Unlock Growth.
We are building predictive brandtech to allow Brand’s to navigate towards and continuously exploit whitespace growth. Our always on tool is aptly named Brand Navigator which helps you find your way in the tumultuous, changing, and vast ocean of business decisions.
Our difference: we are not survey based which is still slow, directional and biased. Rather, we have the data we need, we are accessible by nearly every single brand on the planet regardless of size or category, we have a frictionless sales and onboarding process and our underlying data assets are being built with the vision to power lines of business outside of the branding space for rapid expansion in our later years.
We are hiring. We are looking for new brand partners. We are always open for a chat with possible partners and investors.
Private Investor
May 2019
Valid8 Financial is the global leader in Verified Financial Intelligence (VFI), leveraging the latest in AI and automation technology. Accounting, Legal and Government professionals follow the money faster using Valid8’s VFI Platform to rapidly parse, reconcile and categorize financial data from bank transactions, hand-written checks, and deposit slips.
Within hours, Valid8 Financial:
- Verifies and transforms financial data into courtroom ready evidence
- Traces flow of funds quickly and accurately
- Improves speed and quality of professional opinion
- Increases output without increasing headcount
Hundreds of firms are using Valid8’s software on some of the world’s most complex, high-profile cases.
Schedule a time to meet with our team today.
Private Investor
Sep 2013
OtoNexus Medical Technologies is revolutionizing the diagnosis and management of middle ear infections. The OtoNexus technology platform harnesses the power of ultrasound technology to rapidly and accurately determine both the presence and the type of fluid behind the eardrum, providing a superior alternative to outdated diagnostic methods.
By accurately determining the type of infection, healthcare providers can avoid prescribing antibiotics when they are not needed, helping to combat the growing issues of antibiotic resistance.
Accurate diagnoses and appropriate treatment could reduce healthcare costs by minimizing complications and the need for additional treatments or follow-up visits. Patients will benefit from a faster, non-invasive diagnostic procedure, leading to quicker treatment and potentially shorter recovery times. Healthcare providers will benefit from a reliable and easy-to-use tool that enhances their diagnostic capabilities and supports their decision-making process.
One-use-per-patient proprietary disposable tips incorporating this new patented ultrasound technology create a recurring revenue stream.
The device is a simple, affordable, portable, lightweight, non-invasive tool that provides data in 1-2 seconds on the type of middle ear infection. With this information, healthcare providers can accurately assess middle ear infections and responsibly treat them with antibiotics when appropriate.
Experience · 7 entries
All (7)
Investments (4)
Founder (2)
2020
Private Investor
Jan 2020
Brand’s First Predictive Platform to Unlock Growth.
We are building predictive brandtech to allow Brand’s to navigate towards and continuously exploit whitespace growth. Our always on tool is aptly named Brand Navigator which helps you find your way in the tumultuous, changing, and vast ocean of business decisions.
Our difference: we are not survey based which is still slow, directional and biased. Rather, we have the data we need, we are accessible by nearly every single brand on the planet regardless of size or category, we have a frictionless sales and onboarding process and our underlying data assets are being built with the vision to power lines of business outside of the branding space for rapid expansion in our later years.
We are hiring. We are looking for new brand partners. We are always open for a chat with possible partners and investors.
2019
Private Investor
May 2019
Valid8 Financial is the global leader in Verified Financial Intelligence (VFI), leveraging the latest in AI and automation technology. Accounting, Legal and Government professionals follow the money faster using Valid8’s VFI Platform to rapidly parse, reconcile and categorize financial data from bank transactions, hand-written checks, and deposit slips.
Within hours, Valid8 Financial:
- Verifies and transforms financial data into courtroom ready evidence
- Traces flow of funds quickly and accurately
- Improves speed and quality of professional opinion
- Increases output without increasing headcount
Hundreds of firms are using Valid8’s software on some of the world’s most complex, high-profile cases.
Schedule a time to meet with our team today.
2013
Private Investor
Sep 2013
OtoNexus Medical Technologies is revolutionizing the diagnosis and management of middle ear infections. The OtoNexus technology platform harnesses the power of ultrasound technology to rapidly and accurately determine both the presence and the type of fluid behind the eardrum, providing a superior alternative to outdated diagnostic methods.
By accurately determining the type of infection, healthcare providers can avoid prescribing antibiotics when they are not needed, helping to combat the growing issues of antibiotic resistance.
Accurate diagnoses and appropriate treatment could reduce healthcare costs by minimizing complications and the need for additional treatments or follow-up visits. Patients will benefit from a faster, non-invasive diagnostic procedure, leading to quicker treatment and potentially shorter recovery times. Healthcare providers will benefit from a reliable and easy-to-use tool that enhances their diagnostic capabilities and supports their decision-making process.
One-use-per-patient proprietary disposable tips incorporating this new patented ultrasound technology create a recurring revenue stream.
The device is a simple, affordable, portable, lightweight, non-invasive tool that provides data in 1-2 seconds on the type of middle ear infection. With this information, healthcare providers can accurately assess middle ear infections and responsibly treat them with antibiotics when appropriate.
2012
Real Estate Investor
Mar 2012
We are a Seattle area multi-family real estate investor, NOI-driven asset manager, and property value-add creation firm.
Since 2009 we have been a trusted partner that has generated a 27% IRR and 2.7X Equity Multiple for our investors while dramatically improving the living experience for our residents.
Show all 7 entries ↓
Investment activity
2013–2020 · 4 investments
Recent (last 2 years)Earlier